M1774 Clinical Trials

1 actively recruiting trial across 1 location

Also known as: 2-Amino-6-fluoro-pyrazolo[1,5-a] pyrimidine-3-carboxylic acid [5-fluoro-4-(3-methyl-3H-imidazol-4-yl)-pyridin-3-yl]-amide, MSC2584415A, Tuvusertib, VRT-1363004, VXc-400

Filter by location:

Boston, Massachusetts1 trial

Avelumab and M1774 in ARID1A-mutated Endometrial Cancer

Dana-Farber Cancer Institute

Phase 2

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.